首页 | 本学科首页   官方微博 | 高级检索  
检索        

原发性肝癌合并门静脉癌栓86例治疗体会
引用本文:杜振双,何谦,张诚华.原发性肝癌合并门静脉癌栓86例治疗体会[J].肝胆外科杂志,2014,22(2):131-133.
作者姓名:杜振双  何谦  张诚华
作者单位:杜振双 (解放军第180医院普外科,泉州,362000); 何谦 (解放军第180医院普外科,泉州,362000); 张诚华 (解放军第180医院普外科,泉州,362000);
摘    要:目的探讨肝癌合并门静脉癌栓(PVTT)的有效治疗方法。方法 86例肝癌合并门静脉癌栓患者行肝切除+门静脉取栓+肝动脉、门静脉双灌注化疗栓塞及生物靶向治疗。结果 1年生存率为90%,2年生存率为85%,3年生存率为35%;结论肝切除+门静脉取癌栓+肝动脉、门静脉双灌注化疗栓塞+生物靶向治疗是治疗肝癌合并门静脉癌栓的有效治疗方法。

关 键 词:肝癌  门静脉癌栓  手术治疗

To comprehend the treatment in hepatocellular carcinoma with portal vein tumor thrombus
DU Zhen-shuang,HE Qian,ZHANG Cheng-hua.To comprehend the treatment in hepatocellular carcinoma with portal vein tumor thrombus[J].Journal of Hepatobiliary Surgery,2014,22(2):131-133.
Authors:DU Zhen-shuang  HE Qian  ZHANG Cheng-hua
Institution:.( Department of General Surgery, No. 180 Hospital of PLA, Quanzhou 362008, China)
Abstract:Objective Explore the effective treatment of hepatocellular carcinoma with portal vein tumor thrombus(PVTT). Methods 86 cases of hepatocellular carcinoma with portal vein tumor thrombus in patients with liver resection + portal vein thrombec- tomy + hepatic artery and portal vein infusion chemoembolization and biological targeted therapy. Results 1-year survival rate was 90% , 2-year survival rate was 85% , 3-year survival rate was 35%. Conclusion Liver resection and portal vein tumor thrombus + hepatic artery and portal vein chemoembolization + biological targeted therapy is the effective treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Keywords:liver cancer  portal vein tumor thrombus  surgery  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号